Treatment of Cannabis Use Disorders: A Review of the Literature

REFERENCES

• MacFadden W, Woody G. Cannabis-related disorders. In: Sadock BJ, Sadock VA, eds. Kaplan and Sadock's Comprehensive Textbook of Psychiatry. 7th ed. Philadelphia, Pa.: Lippincott Williams & Wilkins;2000:990–999.
   Google Scholar
• Iverson LL. The Science of Marijuana. New York, NY: Oxford University Press; 2000.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. National Survey on Drug Use and Health. Daily Marijuana Users. In The NSDUH Report. Rockville, MD: Office of Applied Studies Substance Abuse and Mental Health Services, Substance Abuse and Mental Health Services Administration, 2004.
   Google Scholar
• Wagner FA, Anthony JC. From first drug use to drug dependence: developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology. 2002;26:479–488.
   PubMed Web of Science ®Google Scholar
• Dennis M, Babor TF, Roebuck MC, Donaldson J. Changing the focus: the case for recognizing and treating cannabis use disorders. Addiction. 2002;97 Suppl. 1:4–15.
   PubMed Web of Science ®Google Scholar
• Koob GF. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci. 1992;13:177–184.
   PubMed Web of Science ®Google Scholar
• Koob GF. Neural mechanisms of drug reinforcement. Ann NY Acad Sci. 1992;654:171–191.
   PubMed Web of Science ®Google Scholar
• Tanda G, Pontieri FE, Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science. 1997;276:2048–2050.
   PubMed Web of Science ®Google Scholar
• Tanda G, Goldberg SR. Cannabinoids: reward, dependence, and underlying neurochemical mechanisms—a review of recent preclinical data. Psychopharmacology. 2003;169:115–134.
   PubMedGoogle Scholar
• Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW. Abstinence symptoms following oral THC administration to humans. Psychopharmacology. 1999;141(4):385–394.
   Web of Science ®Google Scholar
• Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW. Abstinence symptoms following smoked marijuana in humans. Psychopharmacology. 1999;141:395–404.
   PubMed Web of Science ®Google Scholar
• Kouri EM, Pope HG, Jr. Abstinence symptoms during withdrawal from chronic marijuana use. Exp Clin Psychopharmacol. 2000;8:483–492.
   Google Scholar
• Budney AJ, Novy PL, Hughes JR. Marijuana withdrawal among adults seeking treatment for marijuana dependence. Addiction. 1999;94:1311–1322.
   PubMed Web of Science ®Google Scholar
• Stephens RS, Roffman RA, Simpson EE. Treating adult marijuana dependence: a test of the relapse prevention model. J Consult Clin Psychol. 1994;62:92–99.
   PubMed Web of Science ®Google Scholar
• Copeland J, Swift W, Roffman R, Stephens R. A randomized controlled trial of brief cognitive-behavioral interventions for cannabis use disorder. J Subst Abuse Treat. 2001;21:55–64; discussion 65–66.
   PubMed Web of Science ®Google Scholar
• Henquet C, Krabbendam L, Spauwen J, , et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ. 2005;330:11.
   PubMed Web of Science ®Google Scholar
• Fergusson DM, Horwood LJ. Early onset cannabis use and psychosocial adjustment in young adults. Addiction. 1997;92:279–296.
   PubMed Web of Science ®Google Scholar
• Friedman AS, Terras A, Glassman K. The differential disinhibition effect of marijuana use on violent behavior: a comparison of this effect on a conventional, non-delinquent group versus a delinquent or deviant group. J Addict Dis. 2003;22:63–78.
   PubMed Web of Science ®Google Scholar
• Kingree JB, Braithwaite R, Woodring T. Unprotected sex as a function of alcohol and marijuana use among adolescent detainees. J Adolesc Health. 2000;27:179–185.
   PubMed Web of Science ®Google Scholar
• Kingree JB, Betz H. Risky sexual behavior in relation to marijuana and alcohol use among African-American, male adolescent detainees and their female partners. Drug Alcohol Depend. 2003;72:197–203.
   PubMed Web of Science ®Google Scholar
• Lane SD, Cherek DR, Tcheremissine OV, Lieving LM, Pietras CJ. Acute marijuana effects on human risk taking. Neuropsychopharmacology. 2005;30:800–809.
   PubMed Web of Science ®Google Scholar
• Arseneault L, Cannon M, Witton J, Murray RM. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry. 2004;184:110–117.
   PubMed Web of Science ®Google Scholar
• Budney AJ, Radonovich KJ, Higgins ST, Wong CJ. Adults seeking treatment for marijuana dependence: a comparison with cocaine-dependent treatment seekers. Exp Clin Psychopharmacol. 1998;6:419–426.
   PubMed Web of Science ®Google Scholar
• McRae AL, Budney AJ, Brady KT. Treatment of marijuana dependence: a review of the literature. J Subst Abuse Treat. 2003;24:369–376.
   PubMed Web of Science ®Google Scholar
• Zweben JE, O'Connell K. Strategies for breaking marijuana dependence. J Psychoactive Drugs. 1988;20:121–127.
   PubMed Web of Science ®Google Scholar
• Miller NS, Gold MS, Pottash AC. A 12-step treatment approach for marijuana (Cannabis) dependence. J Subst Abuse Treat. 1989;6:241–250.
   PubMed Web of Science ®Google Scholar
• Morakinyo O. Aversion therapy of cannabis dependence in Nigeria. Drug Alcohol Depend. 1983;12:287–293.
   PubMed Web of Science ®Google Scholar
• Smith JW, Schmeling G, Knowles PL. A marijuana smoking cessation clinical trial utilizing THC-free marijuana, aversion therapy, and self-management counseling. J Subst Abuse Treat. 1988;5:89–98.
   PubMedGoogle Scholar
• Lang E, Engelander M, Brooke T. Report of an integrated brief intervention with self-defined problem cannabis users. J Subst Abuse Treat. 2000;19:111–116.
   PubMedGoogle Scholar
• Stephens RS, Roffman RA, Curtin L. Comparison of extended versus brief treatments for marijuana use. J Consult Clin Psychol. 2000;68:898–908.
   PubMed Web of Science ®Google Scholar
• Martin G, Copeland J, Swift W. The Adolescent Cannabis Check-Up: feasibility of a brief intervention for young cannabis users. J Subst Abuse Treat. 2005;29:207–213.
   PubMed Web of Science ®Google Scholar
• Stephens RS, Roffman RA, Fearer SA, Williams C, Picciano JF, Burke RS. The Marijuana Check-up: reaching users who are ambivalent about change. Addiction. 2004;99:1323–1232.
   PubMed Web of Science ®Google Scholar
• Budney AJ, Higgins ST, Radonovich KJ, Novy PL. Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J Consult Clin Psychol. 2000;68:1051–1061.
   PubMed Web of Science ®Google Scholar
• Budney AJ, Moore BA, Rocha HL, Higgins ST. Clinical trial of abstinence-based vouchers and cognitive-behavioral therapy for cannabis dependence. J Consult Clin Psychol. 2006;74:307–316.
   PubMed Web of Science ®Google Scholar
• Dennis M, Titus JC, Diamond G, , et al. The Cannabis Youth Treatment (CYT) experiment: rationale, study design and analysis plans. Addiction. 2002;97 Suppl. 1:16–34.
   PubMed Web of Science ®Google Scholar
• Diamond G, Godley SH, Liddle HA, , et al. Five outpatient treatment models for adolescent marijuana use: a description of the Cannabis Youth Treatment interventions. Addiction. 2002;97 Suppl. 1:70–83.
   PubMed Web of Science ®Google Scholar
• French MT, Roebuck MC, Dennis ML, , et al. The economic cost of outpatient marijuana treatment for adolescents: findings from a multi-site field experiment. Addiction. 2002;97 Suppl. 1:84–97.
   PubMed Web of Science ®Google Scholar
• Dennis M, Godley SH, Diamond G, , et al. The Cannabis Youth Treatment (CYT) study: main findings from two randomized trials. J Subst Abuse Treat. 2004;27(3):197–213.
   PubMed Web of Science ®Google Scholar
• Stephens RS, Babor TF, Kadden R, Miller M, Marijuana Treatment Project Research Group. The Marijuana Treatment Project: rationale, design and participant characteristics. Addiction. 2002;97 Suppl. 1:109–124.
   PubMed Web of Science ®Google Scholar
• Steinberg KL, Roffman RA, Carroll KM, , et al. Tailoring cannabis dependence treatment for a diverse population. Addiction. 2002;97 Suppl. 1:135–142.
   Google Scholar
• Marijuana Treatment Project Research Group. Brief treatments for cannabis dependence: findings from a randomized multisite trial. J Consult Clin Psychol. 2004;72:455–466.
   PubMed Web of Science ®Google Scholar
• Haney M, Bisaga A, Foltin RW. Interaction between naltrexone and oral THC in heavy marijuana smokers. Psychopharmacology. 2003;166:77–85.
   PubMed Web of Science ®Google Scholar
• Huestis MA, Gorelick DA, Heishman SJ, , et al. Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Arch Gen Psychiatry. 2001;58:322–328.
   PubMed Web of Science ®Google Scholar
• Kosten TR, Kleber HD. Strategies to improve compliance with narcotic antagonists. Am J Drug Alcohol Abuse. 1984;10:249–266.
   PubMed Web of Science ®Google Scholar
• Kleber HD. Treatment of narcotic addicts. Psychiatric Medicine. 1985;3:389–418.
   Google Scholar
• Hart CL, Haney M, Ward AS, Fischman MW, Foltin RW. Effects of oral THC maintenance on smoked marijuana self-administration. Drug Alcohol Depend. 2002;67:301–309.
   PubMed Web of Science ®Google Scholar
• Haney M, Ward AS, Comer SD, Hart CL, Foltin RW, Fischman MW. Bupropion SR worsens mood during marijuana withdrawal in humans. Psychopharmacology. 2001;155:171–179.
   PubMed Web of Science ®Google Scholar
• Haney M, Hart CL, Ward AS, Foltin RW. Nefazodone decreases anxiety during marijuana withdrawal in humans. Psychopharmacology. 2003;165:157–165.
   PubMed Web of Science ®Google Scholar
• Haney M, Hart CL, Vosburg SK, , et al. Marijuana withdrawal in humans: effects of oral THC or divalproex. Neuropsychopharmacology. 2004;29:158–170.
   PubMed Web of Science ®Google Scholar
• Levin FR, McDowell D, Evans SM, , et al. Pharmacotherapy for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodium. Am J Addict. 2004;13:21–32.
   PubMed Web of Science ®Google Scholar
• McDowell D, Levin FR, Brooks DJ, Carpenter K, Garawi F. Treatment of cannabis-dependent treatment seekers: A double-blind comparison of nefazodone, bupropion and placebo. Paper presented at: College on Problems of Drug Dependence 68th Annual Scientific Meeting. Scottsdale, Ariz., 2006.
   Google Scholar
• Geller B, Cooper TB, Watts HE, Cosby CM, Fox LW. Early findings from a pharmacokinetically designed double-blind and placebo-controlled study of lithium for adolescents comorbid with bipolar and substance dependency disorders. Prog Neuropsychopharmacol Biol Psychiatry. 1992;16:281–299.
   PubMed Web of Science ®Google Scholar
• Geller B, Cooper TB, Sun K, , et al. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry. 1998;37:171–178.
   PubMed Web of Science ®Google Scholar
• Cui SS, Bowen RC, Gu GB, Hannesson DK, Yu PH, Zhang X. Prevention of cannabinoid withdrawal syndrome by lithium: involvement of oxytocinergic neuronal activation. J Neurosci. 2001;21:9867–9876.
   PubMed Web of Science ®Google Scholar
• Riggs PD, Hall SK, Mikulich-Gilbertson SK, Lohman M, Kayser A. A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents. J Am Acad Child Adolesc Psychiatry. 2004;43:420–429.
   PubMed Web of Science ®Google Scholar
• Cornelius JR, Salloum IM, Haskett RF, , et al. Fluoxetine versus placebo for the marijuana use of depressed alcoholics. Addict Behav. 1999;24:111–114.
   PubMed Web of Science ®Google Scholar
• Cornelius JR, Salloum IM, Ehler JG, , et al. Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1997;54:700–705.
   PubMed Web of Science ®Google Scholar